You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT ARCHIVES
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 134 No. 9, September 1999 TABLE OF CONTENTS
  Archives
  •  Online Features
  Paper
 This Article
 •Full text
 •PDF
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citation map
 •Citing articles on HighWire
 •Citing articles on Web of Science (13)
 •Contact me when this article is cited
 Related Content
 •Similar articles in this journal
 Topic Collections
 •Surgery, Other
 •Alert me on articles by topic
 Social Bookmarking
  Add to CiteULike Add to Connotea Add to Del.icio.us Add to Digg Add to Reddit Add to Technorati Add to Twitter What's this?

Does Chlamydia pneumoniae Cause Atherosclerosis?

J. Thomas Grayston, MD

Arch Surg. 1999;134:930-934.

Since this article does not have an abstract, we have provided the first 150 words of the full text and any section headings.

INTRODUCTION

This presentation will be in 3 parts. First, there will be an introduction to the microbiology and epidemiology of Chlamydia pneumoniae. I will then present the data that establish an association between C pneumoniae and atherosclerosis, and finally, I will discuss some of the preliminary data concerning a causal role for C pneumoniae and atherosclerosis.


C PNEUMONIAE, A NEWLY DESCRIBED SPECIES OF THE GENUS CHLAMYDIA

History

We isolated the prototype C pneumoniae strain, TW-183, in 1965, but its role in respiratory infection was not demonstrated until the 1980s.1-2 The laboratory designation of the first isolate from respiratory disease was AR-39 and led to the strain name TWAR (from the TW + AR of the first 2 isolates). In 1989, based on DNA homology and morphology of the elementary body, the TWAR organism was established as a new third species of the genus Chlamydia and named C pneumoniae after the most commonly recognized clinical syndrome associated with . . . [Full Text of this Article]

Microbiology

Epidemiology

OBSERVATIONAL STUDIES PROVE THE ASSOCIATION OF C PNEUMONIAE AND ATHEROSCLEROSIS

Seroepidemiologic Study

Direct Demonstration of C pneumoniae in Atherosclerotic Lesions

ETIOLOGIC STUDIES

Animal Models

Mechanisms

Antibiotic Treatment Trials

Retrospective Studies.

Prospective Studies.

CONCLUSIONS

From the Department of Epidemiology, University of Washington, Seattle.



Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter     What's this?

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Chlamydia pneumoniae Serology Is Associated With Thrombosis-Related but Not With Plaque-Related Microembolization During Carotid Endarterectomy
Vainas et al.
Stroke 2002;33:1249-1254.
ABSTRACT | FULL TEXT  

Expression of Chlamydia pneumoniae Polymorphic Membrane Protein Family Genes
Grimwood et al.
Infect. Immun. 2001;69:2383-2389.
ABSTRACT | FULL TEXT  

Closing in on Chlamydia and its intracellular bag of tricks
Bavoil et al.
Microbiology 2000;146:2723-2731.
FULL TEXT  

Secondary Prevention Antibiotic Treatment Trials for Coronary Artery Disease
Grayston
Circulation 2000;102:1742-1743.
FULL TEXT  

Infectious Agents Are Not Necessary for Murine Atherogenesis
Wright et al.
JEM 2000;191:1437-1442.
ABSTRACT | FULL TEXT  

Association Between Polymorphism in the Chemokine Receptor CX3CR1 and Coronary Vascular Endothelial Dysfunction and Atherosclerosis
McDermott et al.
Circ. Res. 2001;89:401-407.
ABSTRACT | FULL TEXT  





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 1999 American Medical Association. All Rights Reserved.